Published in Gut on April 01, 2010
Budesonide in Patients With Immune Mediated Enteropathies | NCT03866538
The Oslo definitions for coeliac disease and related terms. Gut (2012) 5.76
ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol (2013) 4.36
The diagnosis and treatment of celiac disease. Dtsch Arztebl Int (2013) 2.88
Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut (2014) 2.36
Capsule endoscopy in nonresponsive celiac disease. Gastrointest Endosc (2011) 1.54
Quantitative estimates of motility from videocapsule endoscopy are useful to discern celiac patients from controls. Dig Dis Sci (2012) 1.47
Advances in diagnosis and management of celiac disease. Gastroenterology (2015) 1.17
Celiac disease: management of persistent symptoms in patients on a gluten-free diet. World J Gastroenterol (2012) 1.07
Pathophysiology of celiac disease. Gastrointest Endosc Clin N Am (2012) 1.05
Review article: coeliac disease, new approaches to therapy. Aliment Pharmacol Ther (2012) 1.04
Trace gluten contamination may play a role in mucosal and clinical recovery in a subgroup of diet-adherent non-responsive celiac disease patients. BMC Gastroenterol (2013) 0.98
Update on celiac disease - etiology, differential diagnosis, drug targets, and management advances. Clin Exp Gastroenterol (2011) 0.97
Refractory celiac disease: from bench to bedside. Semin Immunopathol (2012) 0.95
Celiac disease diagnosis and management: a 46-year-old woman with anemia. JAMA (2011) 0.93
Diarrhoea due to small bowel diseases. Best Pract Res Clin Gastroenterol (2012) 0.90
Update on the diagnosis and management of refractory coeliac disease. Gastroenterol Res Pract (2013) 0.88
The potential utility of tight junction regulation in celiac disease: focus on larazotide acetate. Therap Adv Gastroenterol (2016) 0.86
The management of refractory coeliac disease. Ther Adv Chronic Dis (2013) 0.83
Celiac disease and persistent symptoms. Clin Gastroenterol Hepatol (2010) 0.81
Serum parameters in the spectrum of coeliac disease: beyond standard antibody testing--a cohort study. BMC Gastroenterol (2012) 0.80
Mechanisms and management of refractory coeliac disease. Nat Rev Gastroenterol Hepatol (2015) 0.80
Remission of Refractory Celiac Disease With Infliximab in a Pediatric Patient. ACG Case Rep J (2015) 0.80
Recognising and Managing Refractory Coeliac Disease: A Tertiary Centre Experience. Nutrients (2015) 0.79
Optimal strategies to identify aberrant intra-epithelial lymphocytes in refractory coeliac disease. J Clin Immunol (2014) 0.79
Salivary proline-rich proteins and gluten: Do structural similarities suggest a role in celiac disease? Proteomics Clin Appl (2015) 0.79
Coeliac Disease - New Pathophysiological Findings and Their Implications for Therapy. Viszeralmedizin (2014) 0.79
The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet. Semin Immunopathol (2012) 0.78
Elderly Onset Celiac Disease: A Narrative Review. Clin Med Insights Gastroenterol (2016) 0.78
Abnormal thymic stromal lymphopoietin expression in the duodenal mucosa of patients with coeliac disease. Gut (2015) 0.77
Maize prolamins could induce a gluten-like cellular immune response in some celiac disease patients. Nutrients (2013) 0.77
Patients with celiac disease and B-cell lymphoma have a better prognosis than those with T-cell lymphoma. Clin Gastroenterol Hepatol (2010) 0.77
Creation of a model to predict survival in patients with refractory coeliac disease using a multinational registry. Aliment Pharmacol Ther (2016) 0.77
A 37-year-old woman with refractory coeliac disease type II disease treated by stem cell transplantation. BMJ Case Rep (2015) 0.75
Pediatric Celiac Disease: Follow-Up in the Spotlight. Adv Nutr (2017) 0.75
Outcome of Referrals for Non-Responsive Celiac Disease in a Tertiary Center: Low Incidence of Refractory Celiac Disease in the Netherlands. Clin Transl Gastroenterol (2017) 0.75
Clinically undiagnosed enteropathy associated T-cell lymphoma type II presenting with prolonged lower gastrointestinal tract symptoms: report of an autopsy case and review of diagnostic challenges and clinicopathological correlation. J Gastrointest Oncol (2013) 0.75
Salivary Gluten Degradation and Oral Microbial Profiles in Health and Celiac Disease. Appl Environ Microbiol (2017) 0.75
Improving outcomes of refractory celiac disease - current and emerging treatment strategies. Clin Exp Gastroenterol (2016) 0.75
Hemophagocytic Lymphohistiocytic Syndrome and Enteropathy-Associated T-cell Lymphoma in a Patient with Refractory Celiac Disease. ACG Case Rep J (2014) 0.75
Modern diagnosis of celiac disease and relevant differential diagnoses in the case of cereal intolerance. Allergo J Int (2014) 0.75
Open-Capsule Budesonide for Refractory Celiac Disease. Am J Gastroenterol (2017) 0.75
Coeliac disease screening is suboptimal in a tertiary gastroenterology setting. Postgrad Med J (2017) 0.75
Clinical and Histologic Mimickers of Celiac Disease. Clin Transl Gastroenterol (2017) 0.75
[Histological diagnosis and complications of celiac disease. Update according to the new S2k guidelines]. Pathologe (2015) 0.75
Celiac disease. N Engl J Med (2007) 10.98
American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology (2006) 4.41
Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology (2009) 3.73
Increasing prevalence of coeliac disease over time. Aliment Pharmacol Ther (2007) 3.53
Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet (2000) 3.47
Coeliac disease and malignancy. Lancet (1983) 3.30
Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology (2003) 3.05
Coeliac disease. Lancet (2009) 3.03
The prevalence and causes of chronic diarrhea in patients with celiac sprue treated with a gluten-free diet. Gastroenterology (1997) 2.85
Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo-controlled trial. Gut (2008) 2.64
Enteropathy-type intestinal T-cell lymphoma: clinical features and treatment of 31 patients in a single center. J Clin Oncol (2000) 2.55
Systematic review: the use of serology to exclude or diagnose coeliac disease (a comparison of the endomysial and tissue transglutaminase antibody tests). Aliment Pharmacol Ther (2006) 2.49
Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology (2008) 2.39
Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study. Gastroenterology (2009) 2.16
Cladribine therapy in refractory celiac disease with aberrant T cells. Clin Gastroenterol Hepatol (2006) 2.04
Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease. Lancet (1994) 2.04
Effect of a gluten-free diet on gastrointestinal symptoms in celiac disease. Am J Clin Nutr (2004) 1.97
Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut (2007) 1.92
Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol (2007) 1.82
Disappointing outcome of autologous stem cell transplantation for enteropathy-associated T-cell lymphoma. Dig Liver Dis (2007) 1.79
Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol (2002) 1.79
Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology (1998) 1.71
Alemtuzumab for refractory celiac disease in a patient at risk for enteropathy-associated T-cell lymphoma. N Engl J Med (2006) 1.69
Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology (2008) 1.63
Refractory coeliac disease. Best Pract Res Clin Gastroenterol (2005) 1.61
The value of wireless capsule endoscopy in patients with complicated celiac disease. Gastrointest Endosc (2005) 1.61
When is a coeliac a coeliac? Report of a working group of the United European Gastroenterology Week in Amsterdam, 2001. Eur J Gastroenterol Hepatol (2001) 1.60
Aberrant T-lymphocytes in refractory coeliac disease are not strictly confined to a small intestinal intraepithelial localization. Cytometry B Clin Cytom (2009) 1.56
A milligram of gluten a day keeps the mucosal recovery away: a case report. Nutr Rev (2004) 1.56
Celiac disease: from oral tolerance to intestinal inflammation, autoimmunity and lymphomagenesis. Mucosal Immunol (2008) 1.53
Adult autoimmune enteropathy: Mayo Clinic Rochester experience. Clin Gastroenterol Hepatol (2007) 1.51
Incidence of enteropathy--associated T-cell lymphoma: a nation-wide study of a population-based registry in The Netherlands. Scand J Gastroenterol (2008) 1.43
Predictors of family risk for celiac disease: a population-based study. Clin Gastroenterol Hepatol (2008) 1.38
Follow-up of patients with celiac disease: achieving compliance with treatment. Gastroenterology (2005) 1.37
Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol (2004) 1.33
Persistent small bowel mucosal villous atrophy without symptoms in coeliac disease. Aliment Pharmacol Ther (2007) 1.33
Autologous hematopoietic stem cell transplantation in refractory celiac disease with aberrant T cells. Blood (2006) 1.31
Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma. Am J Pathol (1997) 1.29
Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment Pharmacol Ther (2003) 1.28
Genetic background of celiac disease and its clinical implications. Am J Gastroenterol (2008) 1.26
Successful infliximab treatment for steroid-refractory celiac disease: a case report. Gastroenterology (2002) 1.26
Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease. Clin Immunol (2007) 1.26
Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease. J Clin Gastroenterol (2009) 1.25
Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology (2007) 1.25
Budesonide in the treatment of refractory celiac disease. Am J Gastroenterol (2007) 1.23
Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method. Histopathology (2000) 1.22
Systematic review: The evidence base for long-term management of coeliac disease. Aliment Pharmacol Ther (2008) 1.21
Tissue transglutaminase and the stress response. Amino Acids (2007) 1.21
The value of double-balloon enteroscopy in patients with refractory celiac disease. Am J Gastroenterol (2007) 1.19
Gluten-free diet: the medical and nutrition management of celiac disease. Nutr Clin Pract (2006) 1.19
Refractory celiac disease. Gastroenterology (2000) 1.15
Intestinal ulceration and malabsorption syndromes. Gastroenterology (1980) 1.09
Defining gluten refractory enteropathy. Eur J Gastroenterol Hepatol (2001) 1.08
The pathology of malabsorption: current concepts. Histopathology (2007) 1.06
High rates of complications and substantial mortality in both types of refractory sprue. Eur J Gastroenterol Hepatol (2009) 1.06
Refractory sprue syndrome with clonal intraepithelial lymphocytes evolving into overt enteropathy-type intestinal T-cell lymphoma. Digestion (2000) 1.06
Diagnosis of cavitating mesenteric lymph node syndrome in celiac disease using MRI. AJR Am J Roentgenol (2004) 1.05
Skin manifestations of celiac disease. Gastroenterology (2005) 1.05
Cyclosporin in the treatment of adults with refractory coeliac disease--an open pilot study. Aliment Pharmacol Ther (2000) 1.05
Capsule endoscopy in refractory celiac disease. Endoscopy (2007) 1.01
The management of complicated celiac disease. Dig Dis (2007) 1.01
The role of defective mismatch repair in small bowel adenocarcinoma in celiac disease. Cancer Res (2004) 1.01
18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease. J Nucl Med (2006) 0.99
Azathioprine in refractory sprue: results from a prospective, open-label study. Am J Gastroenterol (2002) 0.99
Therapy with budesonide in patients with refractory sprue. Digestion (2006) 0.98
Successful treatment of refractory sprue with cyclosporine. Ann Intern Med (1993) 0.98
A pilot study of recombinant human interleukin-10 in adults with refractory coeliac disease. Eur J Gastroenterol Hepatol (2001) 0.98
Celiac sprue and refractory sprue. Gastroenterology (1978) 0.97
Clinical response to gluten withdrawal is not an indicator of coeliac disease. Scand J Gastroenterol (2008) 0.97
Recurrent partial trisomy 1q22-q44 in clonal intraepithelial lymphocytes in refractory celiac sprue. Gastroenterology (2003) 0.96
Clinical characteristics and long-term outcome of patients with refractory sprue diagnosed at a single institution. Acta Gastroenterol Latinoam (2006) 0.96
Treatment of clonal refractory celiac disease or cryptic intraepithelial lymphoma: A long road from bench to bedside. Clin Gastroenterol Hepatol (2006) 0.96
The world map of celiac disease. Acta Gastroenterol Latinoam (2005) 0.95
Celiac disease and its complications: a time traveller's perspective. Gastroenterology (2008) 0.94
Tailored testing for celiac disease. Ann Intern Med (2007) 0.92
Antibody levels in adult patients with coeliac disease during gluten-free diet: a rapid initial decrease of clinical importance. J Intern Med (2004) 0.91
Antitissue transglutaminase antibodies outside celiac disease. J Pediatr Gastroenterol Nutr (2002) 0.91
Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype. Am J Surg Pathol (2008) 0.90
Defective synthesis or association of T-cell receptor chains underlies loss of surface T-cell receptor-CD3 expression in enteropathy-associated T-cell lymphoma. Blood (2008) 0.88
Novel endoscopic methods for the evaluation of the small-bowel mucosa. Gastrointest Endosc (2007) 0.87
Abdominal computed tomography in refractory coeliac disease and enteropathy associated T-cell lymphoma. World J Gastroenterol (2007) 0.87
Effect of elemental diet on mucosal immunopathology and clinical symptoms in type 1 refractory celiac disease. Clin Gastroenterol Hepatol (2005) 0.83
Alemtuzumab for refractory celiac disease. N Engl J Med (2006) 0.83
A severe but reversible refractory sprue. Gut (2006) 0.83
Tropical sprue. Curr Gastroenterol Rep (2005) 0.82
The presence of small intestinal intraepithelial gamma/delta T-lymphocytes is inversely correlated with lymphoma development in refractory celiac disease. Am J Gastroenterol (2008) 0.80
Tropical Sprue. Curr Treat Options Gastroenterol (2004) 0.80
Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med (2003) 7.80
Multiple common variants for celiac disease influencing immune gene expression. Nat Genet (2010) 6.90
The Oslo definitions for coeliac disease and related terms. Gut (2012) 5.76
Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr (2005) 5.34
The prevalence of celiac disease in the United States. Am J Gastroenterol (2012) 4.77
American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology (2006) 4.41
ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol (2013) 4.36
Increased prevalence and mortality in undiagnosed celiac disease. Gastroenterology (2009) 3.73
Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc (2012) 3.60
A controlled trial of gluten-free diet in patients with irritable bowel syndrome-diarrhea: effects on bowel frequency and intestinal function. Gastroenterology (2013) 3.56
Patients with celiac disease are not followed up adequately. Clin Gastroenterol Hepatol (2012) 2.78
The incidence and risk of celiac disease in a healthy US adult population. Am J Gastroenterol (2012) 2.47
Lymphocytic duodenosis and the spectrum of celiac disease. Am J Gastroenterol (2009) 2.26
Increased risk of systemic lupus erythematosus in 29,000 patients with biopsy-verified celiac disease. J Rheumatol (2012) 2.11
Is it necessary to assess for fat-soluble vitamin deficiencies in pediatric patients with newly diagnosed celiac disease? J Pediatr Gastroenterol Nutr (2014) 2.04
Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity. Am J Gastroenterol (2009) 2.02
Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. Gastroenterology (2010) 2.01
A report on the International Transglutaminase Autoantibody Workshop for Celiac Disease. Am J Gastroenterol (2009) 1.94
Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol (2010) 1.88
Hematologic manifestations of celiac disease. Blood (2006) 1.87
Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study. Mayo Clin Proc (2004) 1.85
The liver in celiac disease. Hepatology (2007) 1.81
Etiology of nonresponsive celiac disease: results of a systematic approach. Am J Gastroenterol (2002) 1.79
Routine duodenal biopsies to exclude celiac disease? Gastrointest Endosc (2003) 1.76
The insensitivity of endoscopic markers in celiac disease. Am J Gastroenterol (2002) 1.70
Increasing incidence of celiac disease in a North American population. Am J Gastroenterol (2013) 1.69
Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms. Clin Gastroenterol Hepatol (2003) 1.66
A prospective, randomized, double-blind, placebo-controlled trial of endoscopic steroid injection therapy for recalcitrant esophageal peptic strictures. Am J Gastroenterol (2005) 1.64
Clinical staging and survival in refractory celiac disease: a single center experience. Gastroenterology (2008) 1.63
Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantation. Liver Int (2008) 1.62
Gluten-free diet and steroid treatment are effective therapy for most patients with collagenous sprue. Clin Gastroenterol Hepatol (2010) 1.58
Adult intussusception in the last 25 years of modern imaging: is surgery still indicated? J Gastrointest Surg (2011) 1.54
Capsule endoscopy in nonresponsive celiac disease. Gastrointest Endosc (2011) 1.54
Anti-bullous pemphigoid 180 and 230 antibodies in a sample of unaffected subjects. Arch Dermatol (2010) 1.52
Screening for celiac disease in a North American population: sequential serology and gastrointestinal symptoms. Am J Gastroenterol (2011) 1.52
Adult autoimmune enteropathy: Mayo Clinic Rochester experience. Clin Gastroenterol Hepatol (2007) 1.51
Celiac disease. Curr Opin Gastroenterol (2010) 1.51
Training in small-bowel capsule endoscopy: assessing and defining competency. Gastrointest Endosc (2013) 1.50
Esophageal function testing with combined multichannel intraluminal impedance and manometry: multicenter study in healthy volunteers. Clin Gastroenterol Hepatol (2003) 1.48
Pathogen-specific risk of celiac disease following bacterial causes of foodborne illness: a retrospective cohort study. Dig Dis Sci (2013) 1.47
Significance of intraepithelial lymphocytosis in small bowel biopsy samples with normal mucosal architecture. Am J Gastroenterol (2003) 1.44
Pregnancy outcome and risk of celiac disease in offspring: a nationwide case-control study. Gastroenterology (2011) 1.44
Loss of sex and age driven differences in the gut microbiome characterize arthritis-susceptible 0401 mice but not arthritis-resistant 0402 mice. PLoS One (2012) 1.42
Predictors of family risk for celiac disease: a population-based study. Clin Gastroenterol Hepatol (2008) 1.38
Dysphagia in inflammatory myopathy: clinical characteristics, treatment strategies, and outcome in 62 patients. Mayo Clin Proc (2007) 1.34
HLA-DQ determines the response to exogenous wheat proteins: a model of gluten sensitivity in transgenic knockout mice. J Immunol (2002) 1.30
Morbidity and mortality among older individuals with undiagnosed celiac disease. Gastroenterology (2010) 1.29
Collagenous gastritis: histopathologic features and association with other gastrointestinal diseases. Am J Surg Pathol (2009) 1.29
Prevalence of small intestine bacterial overgrowth diagnosed by quantitative culture of intestinal aspirate in celiac disease. J Clin Gastroenterol (2009) 1.25
Comparative usefulness of deamidated gliadin antibodies in the diagnosis of celiac disease. Clin Gastroenterol Hepatol (2008) 1.23
A new model for dermatitis herpetiformis that uses HLA-DQ8 transgenic NOD mice. J Clin Invest (2004) 1.23
Dermatitis herpetiformis. Int J Dermatol (2003) 1.23
Hepatitis B vaccine nonresponse and celiac disease. Am J Gastroenterol (2003) 1.20
Gluten-free diet: the medical and nutrition management of celiac disease. Nutr Clin Pract (2006) 1.19
An update in the diagnosis of coeliac disease. Histopathology (2010) 1.18
The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease. Nature (2008) 1.16
Variations in presentations of esophageal involvement in lichen planus. Clin Gastroenterol Hepatol (2010) 1.15
Sensitization to gliadin induces moderate enteropathy and insulitis in nonobese diabetic-DQ8 mice. J Immunol (2011) 1.12
Long-term fracture risk in patients with celiac disease: a population-based study in Olmsted County, Minnesota. Dig Dis Sci (2007) 1.12
Mucosal healing and risk for lymphoproliferative malignancy in celiac disease: a population-based cohort study. Ann Intern Med (2013) 1.11
Autoimmune enteropathy: a review and update of clinical management. Curr Gastroenterol Rep (2012) 1.09
Allergen-specific in vitro cytokine production in adult patients with eosinophilic esophagitis. Dig Dis Sci (2006) 1.07
The Mayo Dysphagia Questionnaire-30: documentation of reliability and validity of a tool for interventional trials in adults with esophageal disease. Dysphagia (2009) 1.06
Diagnosis of cavitating mesenteric lymph node syndrome in celiac disease using MRI. AJR Am J Roentgenol (2004) 1.05
The usefulness of routine small bowel biopsies in evaluation of iron deficiency anemia. J Clin Gastroenterol (2004) 1.04
Comparison of positron emission tomography, computed tomography, and endoscopic ultrasound in the initial staging of patients with esophageal cancer. Mol Imaging Biol (2006) 1.04
Associations between single nucleotide polymorphisms in iron-related genes and iron status in multiethnic populations. PLoS One (2012) 1.03
The copolymer P(HEMA-co-SS) binds gluten and reduces immune response in gluten-sensitized mice and human tissues. Gastroenterology (2011) 1.03
Genome-wide association study identifies genetic loci associated with iron deficiency. PLoS One (2011) 1.01
The role of defective mismatch repair in small bowel adenocarcinoma in celiac disease. Cancer Res (2004) 1.01
Low incidence of spontaneous type 1 diabetes in non-obese diabetic mice raised on gluten-free diets is associated with changes in the intestinal microbiome. PLoS One (2013) 1.00
Silent celiac disease activated by pancreaticoduodenectomy. Dig Dis Sci (2007) 1.00
Cognitive impairment and celiac disease. Arch Neurol (2006) 1.00
Esophageal lichen planus. Arch Pathol Lab Med (2008) 0.99
Celiac disease and autoimmunity in the gut and elsewhere. Gastroenterol Clin North Am (2008) 0.99
Association of HLA-DQ gene with bowel transit, barrier function, and inflammation in irritable bowel syndrome with diarrhea. Am J Physiol Gastrointest Liver Physiol (2012) 0.99
Patients with celiac disease have an increased risk for pancreatitis. Clin Gastroenterol Hepatol (2012) 0.99
Esophageal perforation after placement of wireless Bravo pH probe. Gastrointest Endosc (2006) 0.99
Barrett's esophagus: prevalence in symptomatic relatives. Am J Gastroenterol (2002) 0.98
Induction of antigen-specific tolerance by oral administration of Lactococcus lactis delivered immunodominant DQ8-restricted gliadin peptide in sensitized nonobese diabetic Abo Dq8 transgenic mice. J Immunol (2009) 0.97
Update on celiac disease - etiology, differential diagnosis, drug targets, and management advances. Clin Exp Gastroenterol (2011) 0.97
Copper deficiency in celiac disease. J Clin Gastroenterol (2009) 0.97
Small intestinal bacterial overgrowth: histopathologic features and clinical correlates in an underrecognized entity. Arch Pathol Lab Med (2010) 0.96
Autoimmune pancreatitis, Part II: the relapse. Gastroenterology (2008) 0.95
Celiac disease in the elderly. Gastroenterol Clin North Am (2009) 0.95
New aspects of the diagnosis of celiac disease in children, adolescents, and adults. Mayo Clin Proc (2013) 0.95
Larazotide acetate regulates epithelial tight junctions in vitro and in vivo. Peptides (2012) 0.95
Transglutaminase autoantibodies in dermatitis herpetiformis and celiac sprue. J Invest Dermatol (2007) 0.94
Tailored testing for celiac disease. Ann Intern Med (2007) 0.92
Antibody biomarker discovery through in vitro directed evolution of consensus recognition epitopes. Proc Natl Acad Sci U S A (2013) 0.92
Clinical features of patients with novel Yersinia species. Dig Dis Sci (2002) 0.91
Temporal correlation between chronic cough and gastroesophageal reflux disease. Dig Dis Sci (2003) 0.91
Patient localization of esophageal dysphagia. Dig Dis Sci (2004) 0.90
Celiac disease: advances in treatment via gluten modification. Clin Gastroenterol Hepatol (2012) 0.90
Use of computerized algorithm to identify individuals in need of testing for celiac disease. J Am Med Inform Assoc (2013) 0.89
Innate immunomodulatory effects of cereal grains through induction of IL-10. J Allergy Clin Immunol (2007) 0.89
Rates of endoscopy and endoscopic findings among people with frequent symptoms of gastroesophageal reflux in the community. Am J Gastroenterol (2005) 0.89
Celiac disease in type 1 diabetes mellitus in a North American community: prevalence, serologic screening, and clinical features. Mayo Clin Proc (2005) 0.88
Novel endoscopic methods for the evaluation of the small-bowel mucosa. Gastrointest Endosc (2007) 0.87
Celiac disease, eosinophilic esophagitis and gastroesophageal reflux disease, an adult population-based study. Scand J Gastroenterol (2013) 0.87